Ceramide induces apoptotic cell death in a dose-and time-dependent manner in neuroblastoma SKN-SH cells. Pretreatment with caspase inhibitors blocks cell death, suggesting that a set of caspase activities including caspase 1, as well as caspase 3, are involved in ceramideinduced apoptosis in SKN-SH cells. Treatment with a caspase inhibitor 3 h after ceramide addition did not inhibit cell death, although caspase activity was substantially reduced. Ceramide-induced apoptosis is accompanied by accumulation of p53 followed by an increase of Bax and decrease of Bcl-2 levels. Inhibition of p53 expression with p53 antisense oligonucleotides inhibits apoptosis and prevents the increase in Bax and decrease in Bcl-2. Furthermore, pretreatment with p53 antisense oligonucleotides markedly inhibits the induction of caspase activity. These results suggest that p53 regulates the ratio Bcl-2/Bax and the expression/ activation of caspases during ceramide-induced apoptosis in SKN-SH cells. Caspase inhibition did not alter the expression of p53, Bcl-2 and Bax. Thus ceramideinduced reduction in the Bcl-2/Bax ratio, increase in caspase activity, and apoptosis is dependent upon increases in cellular p53 levels which play a critical role in the regulation of apoptotic cell death.
Introduction
Apoptosis is a cell death process requiring organized involvement of endogenous cellular enzymes (Alnemri et al., 1996) . A major regulator of apoptosis is the Bcl-2 protein (Reed, 1997) , which inhibits apoptosis induced by a wide variety of stimuli including ceramide (El-Assaad et al., 1998) . Bcl-2 blocks apoptosis, prevents caspase activation, and maintains mitochondrial function (Ali et al., 1997) , although the exact mechanism of protection aorded by Bcl-2 is unknown. Bcl-2 forms a heterodimer with a related protein Bax, which opposes the anti-apoptotic function of Bcl-2 (Oltvai et al., 1993) . The pro-apoptotic Bax protein interacts with Bcl-2 via a BH3 domain. The propensity for cell death is determined by the ratio of the level of expression of these two proteins, Bcl-2/Bax (Han et al., 1996; Zha et al., 1996) . Another family of proteins important for cell death includes cysteine proteases, caspases, which are involved in the signaling and implementation of apoptosis in response to a variety of apoptotic stimuli (Martin and Green, 1995) . In many cases caspases are believed to mediate cell death but in other cases caspase inhibition is insucient to inhibit cell death, suggesting alternate or redundant apoptotic mechanisms.
The wild type tumor suppressor protein p53 is involved in the signaling pathways induced by cellular stresses including DNA damage, hypoxia and nucleotide deprivation. p53 induces cell cycle arrest and cell death. Normally cells express low p53 levels due to the extremely short half-life of the protein. Post-transcriptional p53 stabilization, caused by exposure to DNA damaging agents, increases p53 levels. In turn, increased p53 levels either arrest the cell cycle at the G1 phase or induce apoptosis in the case of severe DNA damage (Levine, 1997) . The role of p53 as a cell cycle regulator is mediated by transcriptional activation of a cyclin dependent kinase inhibitor, p21. On the other hand, p53-dependent apoptotic signals are not well characterized. Although it has been suggested that the apoptotic mechanism of p53 requires bax activation (Choisy-Rossi et al., 1998) , bax is dispensable for p53-dependent apoptosis in g-irradiated thymocytes (Knudson et al., 1995) .
Ceramide has been regarded as an important mediator of apoptosis in a growing number of cell types (Brugg et al., 1996) . Addition of cell permeable ceramide analogs induces apoptosis in many cell lines (Mathias et al., 1998) . However, the detailed apoptotic pathway downstream of ceramide has not been elucidated, despite the fact that several targets for ceramide have been identi®ed. Although, it has been shown that overexpression of Bcl-2 inhibits ceramide-induced apoptosis (Allouche et al., 1997; Zhang et al., 1996) , the relevance of changes in Bcl-2 and Bax protein levels in ceramide-induced apoptosis has not been established. In previous studies , ceramide did not increase p53 levels to growthsuppressive concentrations whereas p53 activation enhanced endogenous ceramide levels, suggesting that p53 may function upstream of ceramide in situations where p53 performs a critical regulatory role such as in the presence of actinomycin D or g-irradiation.
Ceramide may also be involved in a p53-independent pathway. Thus, the relevance/role of p53 in ceramideinduced apoptosis is yet to be established (Haupt et al., 1996) .
Our studies were designed to de®ne the roles of apoptosis regulators such as p53, caspases, Bcl2 and Bax during ceramide-induced cell death in SKN-SH cells. We report that p53 expression is increased by ceramide. Bax levels increase and Bcl-2 levels fall in ceramide-induced apoptosis. Blocking the expression of p53 with antisense oligonucleotides results in downregulation of bax and upregulation of Bcl-2. P53 inhibition also results in downregulation of ceramideinduced caspase activation. Taken together, these results suggested that p53 functions upstream of Bcl-2, Bax and caspases in the pro-apoptotic signaling pathway induced by ceramide. Our data with caspase inhibitors (caspase 1 inhibitor Y-VAD-cmk, pan caspase inhibitor z-VAD-fmk, and caspase 3 inhibitor DEVD-CHO) implicate early activation of at least two caspases including caspase 3 in ceramide-induced cell death.
Results

Cell-permeable C2-ceramide induces apoptotic cell death in neuroblastoma SKN-SH cells
Neuroblastoma SKN-SH cells were cultured in media containing 1% FBS for 6 h before ceramide treatment. This is the minimum time necessary to ensure neuronal survival and morphological integrity of mature cells. Induction of cell death by ceramide-induced cytotoxicity was estimated by the MTT reduction assay. When neuroblastoma SKN-SH cells were treated with the cell-permeable C2-ceramide (20 ± 40 mM), they died in a dose-and time-dependent manner ( Figure 1A ). Cell viability was decreased over time of exposure to ceramide, as previously reported in PC12 cells (France-Lanord et al., 1997) . After 24 h, about 50% of the cells were dead. By 48 h, very few viable cells remained.
To investigate the mechanism of SKN-SH cell death by C2-ceramide, morphological features and MTT staining were analysed. The morphological characteristics, viewed by phase-contrast microscopy, of SKN-SH cells after 24 h in the presence of 20 mM C2-ceramide were compatible with cell death by apoptosis ( Figure 1B ). Consistent with cell viability data using the MTT assay, about 50% of cells in the C2-ceramidetreated culture lose their neurites and become rounded and shrunken. Most of the shrunken cells also show membrane blebbing, which is characteristic of apoptotic cell death. The cells that remain viable in the C2-ceramide-treated cultures, are less refractive ( Figure  1B) , and have reduced neurite number and length.
Cells were stained with Hoechst 33258 for nuclear structure analysis. Control cells, maintained in 1% FBS media for 24 h and not exposed to C2-ceramide, have intact, round-shaped nuclei. Occasional nuclei with condensed and fragmented chromatin might be due to the eects of growth in 1% serum for 24 h. By contrast condensation and fragmentation of nuclei are evident in SKN-SH cells treated with 20 mM C2-ceramide for 24 h ( Figure 1B ). Taken together, ceramide-induced cell death in SKN-SH cells is apparent by morphological analysis and MTT staining, consistent with previous results in other kinds of cells (Brugg et al., 1996) . In addition, treatment with protein synthesis inhibitor, cycloheximide or actinomycin D, protects SKN-SH cells from C2-ceramide toxicity suggesting ceramide-induced apoptotic cell death requiring de novo protein synthesis (data not shown). Dihydroceramide (DHCer), a biologically inactive ceramide analog, has no eect on cell viability suggesting that the C2-ceramide-induced SKN-SH cell death is speci®c (Figure 2a ).
Caspases are involved in ceramide-induced SKN-SH cell death
The caspase family has been suggested to play a role in neuronal cell death (Friedlander et al., 1997) . To identify the apoptotic mechanism in ceramide-induced apoptosis, the involvement of caspases was assessed using caspase speci®c tetra-peptide inhibitors: the caspase 1-speci®c inhibitor Y-VAD-cmk; the pan caspase inhibitor z-VAD-fmk; and the caspase 3-like activity inhibitor DEVD-CHO. Cells were treated with one of the inhibitors for 2 h before the addition of 20 mM of C2-ceramide at various concentrations ranging from 100 nM to 30 mM and cell viabilities determined after 24 h using the MTT assay ( Figure  2B ). Each of the inhibitors prevented cell death in a dose dependent manner up to 20 mM. But at 30 mM, cell viability is slightly reduced, suggesting that the inhibitor at high doses has cytotoxic eects.
In contrast to previous results that a caspase 1 inhibitor did not block ceramide-induced cell death in Jurkat cells and AK-5 tumor cells (Mizushima et al., 1996; Anjum et al., 1998) , Y-VAD-cmk increased cell viability from less than 60% to greater than 80%, with its maximal eect at 20 mM. Similarly, z-VAD-fmk and DEVD-CHO enhanced cell viability up to 90% and 80% maximally at 20 mM, respectively. These results are consistent with previous reports that z-VAD-fmk inhibited ceramide-induced apoptosis in PC12 cells (Hart®eld et al., 1997; Anjum et al., 1998) . The pan caspase inhibitor z-VAD-fmk exerted the strongest protective eect. Unexpectedly, at lower concentrations (1 and 10 mM), the protective eect of DEVD-CHO was less than that of Y-VAD-cmk. Co-treatment of z-VAD-fmk to cells, at the same time as they are exposed to C2-ceramide, results in less protection compared to pretreated cells. Furthermore, the post-treatment of cells with z-VAD-fmk 3 h after C2-ceramide did not show protective eects ( Figure 2C ).
We also determined whether z-VAD-fmk could prevent C2-ceramide induced morphological changes and nuclear condensation. As shown in Figure 1B , 20 mM of z-VAD-fmk prevents C2-ceramide-induced nuclear changes. Similarly, the cell morphology of the viable cells cultured in the presence of z-VAD-fmk is more intact than in the absence of z-VAD-fmk, although the number of neurites per each cell is reduced. This result is somewhat contrary to a previous report that z-VAD-fmk failed to prevent cell shrinkage and blebbing in PC12 cell. Together these results provide evidence for the possible involvement of apoptotic proteases as mediators in ceramide-induced apoptosis of SKN-SH cell. To further characterize the involvement of caspase, caspase activity was estimated after C2-ceramide treatment either 2 h before or 3 h after addition of z-VAD-fmk. Caspase activity was increased 1 ± 6 h after C2-ceramide treatment, followed by a gradual decrease (Figure 3) . Pretreatment with z-VAD-fmk eectively prevents the increase in caspase activity. When z-VAD-fmk was added 3 h after C2-ceramide caspase activity is also eectively inhibited.
P53 mediates ceramide-induced caspase activation apoptosis in SKN-SH cells
To explore the relationship between p53 and caspase activity, we determined whether inhibition of p53 expression aected caspase activity. Pretreatment with p53 antisense oligonucleotides strongly inhibited caspase activity (Figure 3 ). Expression levels of p53 were evaluated during ceramide-induced apoptosis, using immunocytochemistry and immunoblotting. In the absence of C2-ceramide, it was dicult to detect p53 ( Figure 4A ). However, treatment with 20 mM of C2-ceramide results in a marked increase in p53 levels. Increased levels are easily measurable 1 h after C2-ceramide exposure, peak in expression at 4 h and then gradually decreasing as the cell death process becomes complete ( Figure 4A ). The contribution of p53 induction to C2-ceramide induced apoptosis was assessed by the use of p53 speci®c antisense oligonucleotides. Pretreatment with p53 antisense oligonucleotides eectively blocks the ceramide-induced increase in p53 levels ( Figure 4B ). Pretreatment with the p53 antisense oligonucleotides is associated with approximately a 90% reduction in apoptotic cells (Figures 1B,  2A ). p53 sense oligonucleotides did not show any eect on cell death induced by ceramide. These results therefore suggest that ceramide-induced apoptosis depends on p53.
Changes of Bcl-2/Bax ratio in ceramide-induced apoptosis in SKN-SH cells
Bcl-2 protects various kinds of cells from cell death induced by ceramide (Wieder et al., 1997) . To determine whether ceramide-induced apoptosis in SKN-SH cells is associated with changes in relative expression of Bcl-2 and Bax, the expression levels of those proteins after C2-ceramide treatment were estimated. The level of Bax protein in SKN-SH cells increased after treatment with 20 mM C2-ceramide ( Figure 5 ). Bax protein up-regulation by C2-ceramide occurred 2 h later than that of p53 (compare Figures  4e and 5e) . To explore a possible interaction between p53 and Bax, we made use of p53 antisense oligonucleotides. Pretreatment with p53 antisense oligonucleotides 6 h before C2-ceramide addition signi®cantly blocked the increase in expression levels of Bax ( Figure 5B ). These results indicate that increases in p53 protein are necessary for the upregulated in expression of Bax. Next we investigated the levels of Bcl-2 during ceramide-induced apoptosis. Bcl-2 is constitutively expressed in SKN-SH cells (Figure 6 ). The expression of the protein decreased gradually and reached a minimum at 6 h after C2-ceramide treatment. The Bcl-2 down-regulation by C2-ceramide was abolished by pretreatment of cells with p53 antisense oligonucleotides (Figure 7) . Thus p53 plays an important role in ceramide-induced increase in Bax levels, decrease in Bcl-2 levels, and apoptosis.
Ceramide-induced induction of p53 is not affected by z-VAD
To determine whether ceramide-induced p53 accumulation requires activation of apoptotic proteases as cellular stress mediators, the per cent of p53 positive cells were measured in control and z-VAD-pretreated cells after ceramide incubation using immunocytochemistry. As shown in Figure 7 , the per cent of p53 positive cells was similar in the presence or absence of z-VAD-fmk, suggesting that p53 accumulation in C2-ceramide-treated SKN-SH cells does not require early activation of z-VAD-fmk sensitive proteases.
Discussion
Although, ceramide has been known as an inducer of apoptosis in various kinds of cells, including neuronal cells (Brugg et al., 1996) , the complex relationships between p53, Bcl-2, Bax and ceramide in the cell death mechanism in human neuronal cells have not been well characterized. Cell death as a result of accumulation of ceramide may possibly be a mechanism of senescence and brain atrophy, since sphingomyelinase, which produces ceramide, has been found to be increased in an age-dependent manner in the (Kim et al., 1997) . The sphingomyelin signal transduction pathway has been implicated in the onset of a senescent phenotype in a cell culture model of senescence (Vaneble et al., 1995) , and aging is accompanied by an elevation in sphingomyelin turnover (Lightle et al., 2000) . The speci®c localization of brain atrophy associated with cell death may be partially explained by the cell type-dependent susceptibility to ceramide. The present study describes a time course of apoptosis-related molecular events occurring in human neuroblastoma SKN-SH cells after C2-ceramide treatment. A typical feature of neuronal apoptosis is a requirement for new mRNA and protein synthesis (Johnson and Deckwerth, 1993) . Mesner et al. (1992) showed that actinomycin D and cycloheximide inhibit apoptosis in neuronal PC12 cells. We also ®nd that gene activation and protein synthesis soon after addition of ceramide is required for apoptosis of SKN-SH cells.
Current evidence suggests that caspases are essential components of a proteolytic cascade that is triggered in response to a death stimulus, having roles in both the regulation and execution stages of apoptosis (for a review see Thornberry, 1997) . In our study, SKN-SH cells were treated with C2-ceramide in the presence of three kinds of cell permeable protease inhibitors. The caspase 1-like activity inhibitor Y-VAD-cmk and the broad-spectrum caspase inhibitor z-VAD-fmk, at concentrations of 10 mM, blocked ceramide-induced cell death. However, higher concentrations (60 mM) were necessary to see a protective eect of the caspase 3-like activity inhibitor, DEVD-CHO, and the extent of protection was less than that of z-VAD-fmk. This is not consistent with reported results that caspase 3 plays a predominant role in ceramide-induced apoptosis in PC 12 cells (Mizushima et al., 1996) . This discrepancy could arise from the possibility is that more than one caspase, including caspase 3, plays an important role in ceramide-induced apoptosis in SKN-SH cells. This possibility is strongly supported by the ®nding that the pan caspase inhibitor z-VADfmk blocks ceramide-induced apoptosis most eectively, possibly because it can block all upstream caspases in the proteolytic activation cascade. Our results that pretreatment with z-VAD-fmk blocked events associated with apoptosis are partially consistent with the previous report using PC12 cells (Hart®eld et al., 1997) . However, in contrast to our observations, cell detachment from the plate, cell shrinkage, and membrane blebbing were not inhibited by z-VAD-fmk in PC12 cells (Hart®eld et al., 1998) . Thus the participation of the caspase pathway in ceramide-induced apoptosis appears to be dependent on neuronal cell type. Furthermore, treatment of cells with z-VAD 3 h after exposure to C2-ceramide does not rescue cell from C2-ceramide induced apoptosis even though caspase activity is inhibited, indicating that early caspase activation is sucient for apoptosis.
Although it has been suggested that genotoxic insults, such as g-irradiation or actinomycin D therapy, induce ceramide accumulation in a p53-dependent manner , the role of p53 in ceramide-induced apoptosis is poorly understood. Our study provides evidence that p53 accumulation is important for apoptosis induced by ceramide in SKN-SH cells. Generally, inducers of p53-dependent apoptosis include DNA damage, certain cytokines, and heat shock (Eizenberg et al., 1995; Graeber et al., 1994; Levine, 1997) . DNA damage is a wellde®ned stimulus for p53-dependent response and is linked to accumulation of the p53 protein in several cell types (Clarke et al., 1993) . From our data it cannot be determined whether p53 accumulation is mediated through DNA damage in SKN-SH cells undergoing ceramide-induced apoptosis. Antisense oligonucleotides to p53 inhibited ceramide-induced cell death as well as accumulation of the p53 protein.
These results suggest that the p53 pathway is downstream of ceramide and that p53 plays an important role in ceramide-induced apoptosis in SKN-SH cells. By contrast, in a recent publication, the ceramide pathway was suggested to be downstream of p53 . This suggestion was based primarily on p53 activation followed by an increase in endogenous ceramide levels in Molt-4 cell death induced by actinomycin D or g-irradiation and the ®ndings of no increase in p53 levels by ceramide. It should be noted, however, that large changes in transcriptional transactivation by p53 are achievable without measureable changes in protein levels (see for a review Levine, 1997) .
While the speci®c function of p53 in apoptosis remains unclear, one suggested mechanism involves the transcriptional transactivation of Bax, a member of the Bcl-2 family that, in relative excess to Bcl-2, is pro-apoptotic. However, since Bax is not necessary for p53-dependent apoptosis in g-irradiated thymocytes, other factors are likely involved. For instance, the transcriptional repression of Bcl-2 by p53 may also contribute to apoptosis (Selvakumaran et al., 1994) . Immunocytochemical and immunoblot analysis indicates that the Bcl-2 protein is constitutively expressed in SKN-SH cells and is decreased by C2-ceramide, while Bax levels are increased. Interestingly, the increase in p53 levels precedes these changes. Changes in Bax and Bcl-2 levels are prevented by inhibition of p53 expression, coincident with the prevention of C2-ceramide-induced apoptosis in SKN-SH cells. These results suggest that elevated levels of p53 mediate the up-regulation of Bax and down regulation of Bcl-2. It has been demonstrated that the interactions between the anti-apoptotic Bcl-2 and pro-apoptotic Bax are critical in determining the fate of the cell (Sedlak et al., 1995; Yang et al., 1995) . Bcl-2 has been shown by several groups to block ceramide-induced apoptosis without signi®cantly interfering with ceramide accumulation (El-Assaad et al., 1998; Allouche et al., 1997; Zhang et al., 1996) .
In conclusion, we suggest that increases in p53 expression, which in turn mediates an increase in the Bax/Bcl-2 ratio and caspase activation, are critical for C2-ceramide induced cell death in SKN-SH cells. These results may have important implications for neuronal cell senescence with aging and disease.
Materials and methods
Cell viability assay (MTT test)
SKN-SH cells were plated on 96-well plates (Nunc) at a density of 15 000 cells/well, in 100 ml of 10% FBS/DMEM without phenol red and incubated for 24 h. Two hours before the end of ceramide treatment, the media was replaced with 90 ml of 1% FBS/DMEM without phenol red. Eleven microliters of MTT solution (10 mg/ml) were added. At the end of ceramide treatment all of the MTT solution was removed. The cells and dye crystals were dissolved by adding 100 ml of 100% DMSO and vortexed for 20 min. Absorbance at 570 nm was measured with an ELISA Reader (Molecular Devices). The assay value obtained upon addition of vehicle was taken as 100% and the value obtained following the addition of 10% Triton X-100 as 0% viability.
Hoechst 33258 staining
Neuronal cultures were ®xed with 4% paraformaldehyde for 5 min onto glass slides. Samples were washed with phosphate-buered saline, stained with 8 mg/ml of the Hoechst dye 33258 for 5 min, washed with distilled water, and mounted in Kaiser's glycerol gelatin. Nuclei were visualized using an Olympus Microscope (Tokyo, Japan). Dead cells and apoptotic bodies were characterized by condensed or fragmented nuclei.
Effect of the p53 antisense oligonucleotides on neuronal viability
To access the role of p53 in the cell viability in ceramidemediated neuronal cell death, antisense 20-mer phosphorothioate oligonucleotides were synthesized and added to the culture medium (®nal concentration of 10 mM) 6 h before addition of ceramide to the culture. The sequence of p53 antisense oligonucleotides (5'-CGCTAGGATCTGACTGC-3') was complementary to the translation initiation site of the mouse p53 mRNA. p53 sense oligonucleotides (5'-GCAGTCAGATCCTAGCG-3') were used as negative control. After exposure of neurons to 20 mM ceramide, the eects of these oligonucleotides on caspase activity, the expression of Bcl2 and Bax, and neuronal viability were examined. The eectiveness of the oligonucleotides for suppression of expression of p53 was con®rmed by immunocytochemistry of SKN-SH cells after exposure to 20 mM ceramide in the presence of the oligonucleotides.
Immunoblotting
After the treatment, the cells were washed twice with ice-cold PBS, lysis buer (RIPA buer) was added, and then collected by scraping using rubber policeman. Cell extracts were lysed by sonication, centrifuged for 10 min at 14 000 r.p.m., and the supernatant (RIPA lysate) was used for immunoblotting. Protein concentrations of RIPA lysates were determined by the method of Bradford (Bradford, 1976 ) using BSA as a standard. Sample buer was added to aliquots (50 mg of protein) of lysates, boiled for 3 min, and then resolved by SDS ± PAGE under reducing conditions (Laemmli, 1970) . The resolved proteins were transferred to PVDF membranes and immunoblotted with anti-p53, anti-Bax, and anti-Bcl-2 antibodies (Santa Cruz). The blots were washed and followed by detection with an ECL detection system (Amersham). In some instances, blots were stripped by incubation in stripping buer (62.5 mM Tris, pH 6.8, 100 mM b-mercaptoethanol, and 2% SDS) for 30 min at 508C and then reprobed with other antibodies.
Immunocytochemistry
Cells, collected using cytospin, were ®xed in 4% paraformaldehyde in 0.1 M phosphate buer (pH 7.4) for 10 min. They were then treated with 0.3% H 2 O 2 for 10 min to eliminate endogenous peroxidase and incubated with 10% normal goat serum (ABC kit, Zymed) for 30 min. Cells were incubated with p53 antibodies (1 : 100) for 1 h in 10% normal goat serum. After primary antibody incubation, a biotinylated secondary antibody (ABC kit, Zymed) was added for 1 h, followed by incubation with a streptavidin peroxidase conjugate (ABC kit, Zymed) for 1 h. Antigen localization was then visualized with a 3,3'-diaminobenzidine staining kit (Zymed). p53 positive stained cells were counted and represented as a percentage of all cells.
Caspase assay with fluorogenic substrates
For assaying caspase activity in SKN-SH cells, monolayers of cultures cells (2+10 6 cells) were harvested from a 60 mm dish and lysed with 1 ml of cell lysis buer (10 mM Tris-Hcl, pH 7.4, 10 mM NaH 2 PO 4 /NaHPO 4 , pH 7.4, 130 mM NaCl, 1% Triton X-100, 10 mM NaPP). Fifty ml of the lysed sample was added into 200 ml of HEPES buer (100 mM HEPES, pH 7.5, 10% sucrose, 0.1% CHAPS, 10 mM DTT) containing 40 mM of z-VAD-AFC (ESP, CA.) for 1 h. Caspase activity was measured with excitation at 400 nm and emission at 505 nm.
Statistical analysis
Data are expressed as mean+s.e.m. values. Using an SPSS program (SPSS Inc., Chicago, USA), Kruskal ± Wallis and ANOVA tests were applied to study the relationship between the dierent variables. A P50.05 was considered to be signi®cant.
